{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:14:48Z","timestamp":1759342488584},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neurol.2012.05.014","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T11:05:29Z","timestamp":1350990329000},"page":"142-153","source":"Crossref","is-referenced-by-count":19,"title":["Enc\u00e9phalites dysimmunitaires, donn\u00e9es cliniques, radiologiques et immunologiques"],"prefix":"10.1016","volume":"169","author":[{"given":"J.","family":"Aupy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Collongues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tranchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"De Seze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 6","key":"10.1016\/j.neurol.2012.05.014_bib0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/120.6.923","article-title":"Limbic encephalitis and small cell lung cancer. Clinical and immunological features","volume":"120","author":"Alamowitch","year":"1997","journal-title":"Brain"},{"issue":"Pt 8","key":"10.1016\/j.neurol.2012.05.014_bib0010","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.2006.100644","article-title":"Autoimmune limbic encephalitis in 39\u00a0patients: immunophenotypes and outcomes","volume":"78","author":"Bataller","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.neurol.2012.05.014_bib0020","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.55.12.1823","article-title":"Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy","volume":"55","author":"Bien","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2012.05.014_bib0025","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"issue":"Pt 8","key":"10.1016\/j.neurol.2012.05.014_bib0035","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neurol.2012.05.014_bib0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neurol.2012.05.014_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1528-1167.2011.03034.x","article-title":"Molecular cascades that mediate the influence of inflammation on epilepsy","volume":"52","author":"Friedman","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.neurol.2012.05.014_bib0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181f11d65","article-title":"Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations","volume":"75","author":"Granerod","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2012.05.014_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.35.4.538","article-title":"Neuronal antinuclear antibody in sensory neuronopathy from lung cancer","volume":"35","author":"Graus","year":"1985","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2012.05.014_bib0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 7","key":"10.1016\/j.neurol.2012.05.014_bib0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50\u00a0patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2012.05.014_bib0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2012.05.014_bib0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.1270","article-title":"Are the \u201cnewly discovered\u201d paraneoplastic anticollapsin response-mediator protein 5\u00a0antibodies simply anti-CV2\u00a0antibodies?","volume":"50","author":"Honnorat","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2012.05.014_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14\u00a0patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2012.05.014_bib0095","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1\u00a0potassium channel-complex proteins leucine-rich, glioma inactivated 1\u00a0protein and contactin-associated protein-2\u00a0in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2012.05.014_bib0100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede LGI1\u00a0antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2012.05.014_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WCO.0b013e3283446f05","article-title":"Autoimmune epilepsies","volume":"24","author":"Irani","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2012.05.014_bib0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1\u00a0as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2012.05.014_bib0130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.neurol.2012.05.014_bib0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2012.05.014_bib0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2009.10.020","article-title":"Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature","volume":"17","author":"Mikati","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archneurol.2009.5","article-title":"Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy","volume":"66","author":"Niehusmann","year":"2009","journal-title":"Arch Neurol"},{"issue":"19","key":"10.1016\/j.neurol.2012.05.014_bib0150","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.0b013e3181fc2a06","article-title":"Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin","volume":"75","author":"Pruss","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2012.05.014_bib0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"Molecular and clinical diversity in paraneoplastic immunity to Ma proteins","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"issue":"Pt 10","key":"10.1016\/j.neurol.2012.05.014_bib0160","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","article-title":"Anti-Hu-associated brainstem encephalitis","volume":"80","author":"Saiz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes","volume":"253","author":"Shams\u2019ili","year":"2006","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2012.05.014_bib0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02592447","article-title":"Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind\/dose finding clinical study","volume":"24","author":"van Rijckevorsel-Harmant","year":"1994","journal-title":"Int J Clin Lab Res"},{"issue":"11","key":"10.1016\/j.neurol.2012.05.014_bib0180","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neurol.2012.05.014_bib0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2012.05.014_bib0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2012.05.014_bib0195","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871200937X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871200937X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T18:56:10Z","timestamp":1542653770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871200937X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S003537871200937X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2012.05.014","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}